Loading…
Trolox Prevents Osteoclastogenesis by Suppressing RANKL Expression and SignalingS
Excessive receptor activator of NF-κB ligand (RANKL) signaling causes enhanced osteoclast formation and bone resorption. Thus, down-regulation of RANKL expression or its downstream signals may be a therapeutic approach to the treatment of pathological bone loss. In this study, we investigated the ef...
Saved in:
Published in: | The Journal of biological chemistry 2009-05, Vol.284 (20), p.13725-13734 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Excessive receptor activator of NF-κB ligand (RANKL) signaling causes
enhanced osteoclast formation and bone resorption. Thus, down-regulation of
RANKL expression or its downstream signals may be a therapeutic approach to
the treatment of pathological bone loss. In this study, we investigated the
effects of Trolox, a water-soluble vitamin E analogue, on osteoclastogenesis
and RANKL signaling. Trolox potently inhibited interleukin-1-induced
osteoclast formation in bone marrow cell-osteoblast coculture by abrogating
RANKL induction in osteoblasts. This RANKL reduction was attributed to the
reduced production of prostaglandin E
2
via a down-regulation of
cyclooxygenase-2 activity. We also found that Trolox inhibited osteoclast
formation from bone marrow macrophages induced by macrophage
colony-stimulating factor plus RANKL in a reversible manner. Trolox was
effective only when present during the early stage of culture, which implies
that it targets early osteoclast precursors. Pretreatment with Trolox did not
affect RANKL-induced early signaling pathways, including MAPKs, NF-κB,
and Akt. We found that Trolox down-regulated the induction by RANKL of c-Fos
protein by suppressing its translation. Ectopic overexpression of c-Fos
rescued the inhibition of osteoclastogenesis by Trolox in bone marrow
macrophages. Trolox also suppressed interleukin-1-induced osteoclast formation
and bone loss in mouse calvarial bone. Taken together, our findings indicate
that Trolox prevents osteoclast formation and bone loss by inhibiting both
RANKL induction in osteoblasts and c-Fos expression in osteoclast
precursors. |
---|---|
ISSN: | 0021-9258 1083-351X |
DOI: | 10.1074/jbc.M806941200 |